Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The Queen's University of Belfast has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners across 4 art units, giving each active matter a distinct examination assignment.
BEHM, HARRY RAYMOND is the busiest examiner, with 1 pending matter. Counsel should manage responses on an application-by-application basis and account for the separate art-unit settings when addressing biotechnology and pharmaceutical issues.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEHM, HARRY RAYMOND | 1 | 79.6% | +7.3% |
| PALENIK, JEFFREY T | 1 | 53.5% | +27.0% |
| MILLER, DALE R | 1 | 62.5% | +17.6% |
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18876519 | AC TO DC POWER CONVERSION METHOD AND SYSTEM | BEHM, HARRY RAYMOND | — |
| 18550874 | SUTURES | PALENIK, JEFFREY T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17872533 | SEPARATION OF RARE EARTH METALS | HERNANDEZ, JACKSON J | 28d overdue |
| 18550874 | SUTURES | PALENIK, JEFFREY T | — |
| 18034651 | IMMUNOMODULATORY AGENT | MILLER, DALE R | — |
| Art Unit | Apps |
|---|---|
| 2838 | 1 |
| 1615 | 1 |
| 1693 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18876519 | AC TO DC POWER CONVERSION METHOD AND SYSTEM | BEHM, HARRY RAYMOND | 2838 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18550874 | SUTURES | PALENIK, JEFFREY T | 1615 | §102§103 | Final Rejection | — | Pending | Sep 15, 2023 |
| 18034651 | IMMUNOMODULATORY AGENT | MILLER, DALE R | 1693 | §103DP | Final Rejection | — | Pending | Apr 28, 2023 |
| 17872533 | SEPARATION OF RARE EARTH METALS | HERNANDEZ, JACKSON J | 1627 | §103Other | Non-Final OA | 28d overdue | Pending | Jul 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Queen's University of Belfast has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Harry Raymond Behm has the most, with 1 of The Queen's University of Belfast's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
